Bangladesh, April 28 -- US pharmaceutical giant Moderna is under serious scrutiny in the United Kingdom after allegations emerged that the company offered cash payments and gifts to children to participate in COVID-19 booster trials. According to The Telegraph, Modernas practices have led to multiple breaches of the UKs pharmaceutical industry code, resulting in significant fines and the looming threat of suspension or expulsion from a key industry body.

The Association of the British Pharmaceutical Industry (ABPI), which Moderna joined only in 2023, has launched a formal audit into the companys conduct. A decision on possible disciplinary action is expected within days. Should Moderna face suspension, it would be only the tenth company ...